share_log

China Resources Medical Holdings Insider Lowered Holding By 100% During Last Year

China Resources Medical Holdings Insider Lowered Holding By 100% During Last Year

中國資源醫療控股公司內部人士在過去一年中減少持股比例100%
Simply Wall St ·  06:58

Looking at China Resources Medical Holdings Company Limited's (HKG:1515 ) insider transactions over the last year, we can see that insiders were net sellers. That is, there were more number of shares sold by insiders than there were purchased.

通過查看中國醫療資源控股有限公司(HKG:1515)過去一年的內部交易,我們發現內部人員是淨賣家。也就是說,內部人員賣出的股票數量多於購買的數量。

Although we don't think shareholders should simply follow insider transactions, we would consider it foolish to ignore insider transactions altogether.

雖然我們不認爲股東應該簡單地跟隨內部交易,但完全忽略內部交易將是愚蠢的。

China Resources Medical Holdings Insider Transactions Over The Last Year

中國醫療資源控股過去一年內部交易情況

In the last twelve months, the biggest single sale by an insider was when the Independent Non-Executive Director, Ting Yuk Wu, sold HK$2.6m worth of shares at a price of HK$4.41 per share. That means that an insider was selling shares at around the current price of HK$4.20. We generally don't like to see insider selling, but the lower the sale price, the more it concerns us. In this case, the big sale took place at around the current price, so it's not too bad (but it's still not a positive). Ting Yuk Wu was the only individual insider to sell over the last year.

在過去十二個月中,獨立非執行董事胡霆煜是個人內部人員中進行的最大單次交易,他以每股4.41港元的價格賣出價值260萬港元的股票。這意味着內部人員在大約當前價格4.20港元時出售股票。通常我們不喜歡看到內部人員賣出,但賣出價格越低,我們就越擔憂。在這種情況下,大宗交易發生在當前價格附近,所以情況還不算太糟糕(但仍然不算積極)。胡霆煜是過去一年中唯一一位售出股票的個人內部人員。

Ting Yuk Wu sold a total of 1.00m shares over the year at an average price of CN¥4.38. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

胡霆煜在過去一年內以平均價格4.38人民幣售出了100萬股。您可以在下方看到內幕交易的視覺描述(按公司和個人分類)。如果您想了解到底是誰以及以多少價格何時出售的,請直接點擊下方的圖表!

big
SEHK:1515 Insider Trading Volume November 5th 2024
SEHK:1515內幕交易量2024年11月5日

If you like to buy stocks that insiders are buying, rather than selling, then you might just love this free list of companies. (Hint: Most of them are flying under the radar).

如果你喜歡購買內部人員正在購買而不是銷售的股票,那麼你可能會喜歡這份免費的公司列表。(提示:它們中的大部分都被忽視了。)

Insider Ownership

內部人員持股情況

I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. From what we can see in our data, insiders own only about HK$2.0m worth of China Resources Medical Holdings shares. However, it's possible that insiders might have an indirect interest through a more complex structure. We might be missing something but that seems like very low insider ownership.

我喜歡查看內部人士在一家公司中擁有多少股份,以幫助我了解他們與內部人士的一致程度。高比例的內部人士持股通常會使公司領導更加關注股東利益。從我們的數據中可以看到,內部人士僅持有約200萬港元的華潤醫藥股份。但是,內部人士可能通過更復雜的結構間接持有利益。我們可能漏掉了某些內容,但這似乎是非常低的內部持股比例。

So What Does This Data Suggest About China Resources Medical Holdings Insiders?

那麼,這些數據對華潤醫藥股份內部人士有何含義?

The fact that there have been no China Resources Medical Holdings insider transactions recently certainly doesn't bother us. The insider transactions at China Resources Medical Holdings are not inspiring us to buy. We also note that, as far as we can see, insider ownership is fairly low, compared to other companies. So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. While conducting our analysis, we found that China Resources Medical Holdings has 2 warning signs and it would be unwise to ignore them.

最近華潤醫藥股份沒有內部人士交易的事實確實並不讓我們擔憂。華潤醫藥股份的內部交易並沒有激勵我們購買。我們還注意到,就我們所見,與其他公司相比,內部持股比例相對較低。因此,了解內部人士在購買或出售方面的行爲固然有幫助,了解特定公司面臨的風險也很有幫助。在進行分析時,我們發現華潤醫藥股份存在2條警示信號,忽視它們將是不明智的。

But note: China Resources Medical Holdings may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

注意:中國資源醫療控股可能不是最佳買入股票。因此,請查看具有高roe和低債務的有趣公司的免費名單。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

對於本文而言,內部人是指向相關監管機構報告其交易的個人。我們目前僅考慮公開市場交易和直接利益的私人處置,但不包括衍生交易或間接利益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接與我們聯繫。或者,發送電子郵件至editorial-team @ simplywallst.com。
Simply Wall St的這篇文章是一般性質的。我們僅基於歷史數據和分析師預測提供評論,使用公正的方法,我們的文章並非意在提供財務建議。這並不構成買入或賣出任何股票的建議,並且不考慮您的目標或財務狀況。我們旨在爲您帶來基於基礎數據驅動的長期聚焦分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St對提及的任何股票都沒有持倉。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論